Inpharma Weekly

, Volume 1094, Issue 1, pp 9–10 | Cite as

A rash of innovative options for psoriasis

  • Wayne Elwood
Newsletter Article


Psoriasis is a highly variable disease that is difficult to treat. It is characterised by periodic exacerbations and remissions and affects 1-3% of the population worldwide. There are a number of abnormalities in the skin of patients with psoriasis and increasing evidence points to an underlying T lymphocyte-mediated autoimmune process. Several innovative therapies undergoing development for use in this condition were discussed at the 19th World Congress of Dermatology [ Sydney, Australia; June 1997 ].


Psoriasis 19th World Evidence Point Autoimmune Process Variable Disease 

Copyright information

© Adis International Ltd 1997

Authors and Affiliations

  • Wayne Elwood

There are no affiliations available

Personalised recommendations